TW200640945A - Mutants of the fluorescent protein CGFP, and their use - Google Patents

Mutants of the fluorescent protein CGFP, and their use

Info

Publication number
TW200640945A
TW200640945A TW095103672A TW95103672A TW200640945A TW 200640945 A TW200640945 A TW 200640945A TW 095103672 A TW095103672 A TW 095103672A TW 95103672 A TW95103672 A TW 95103672A TW 200640945 A TW200640945 A TW 200640945A
Authority
TW
Taiwan
Prior art keywords
mutants
fluorescent protein
protein cgfp
cgfp
nucleotide
Prior art date
Application number
TW095103672A
Other languages
Chinese (zh)
Inventor
Stefan Golz
Eugene Vysotski
Svetlana Markova
Ludmilla Burakova
Ludmilla Frank
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of TW200640945A publication Critical patent/TW200640945A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae

Abstract

The invention relates to the nucleotide and amino acid sequences, and to the activities and uses, of mutants of the fluorescent protein CGFP.
TW095103672A 2005-02-05 2006-02-03 Mutants of the fluorescent protein CGFP, and their use TW200640945A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE200510005438 DE102005005438A1 (en) 2005-02-05 2005-02-05 Mutants of the fluorescent protein CGFPs, as well as their use

Publications (1)

Publication Number Publication Date
TW200640945A true TW200640945A (en) 2006-12-01

Family

ID=36128319

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095103672A TW200640945A (en) 2005-02-05 2006-02-03 Mutants of the fluorescent protein CGFP, and their use

Country Status (3)

Country Link
DE (1) DE102005005438A1 (en)
TW (1) TW200640945A (en)
WO (1) WO2006081976A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006026586A1 (en) * 2006-06-07 2007-12-13 Bayer Healthcare Ag Fluorescent proteins wfCGFP, as well as their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117679A (en) * 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
WO2000008054A1 (en) * 1998-08-08 2000-02-17 Imperial Cancer Research Technology Limited Modified green fluorescent protein
AU2002254173A1 (en) * 2001-03-12 2002-10-08 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The Unive Oxidation-reduction sensitive green fluorescent protein variants
DE10257354A1 (en) * 2002-12-09 2004-07-08 Bayer Healthcare Ag Isolated fluorescent protein CGFP and its use

Also Published As

Publication number Publication date
WO2006081976A1 (en) 2006-08-10
DE102005005438A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
WO2006131928A8 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
TW200732349A (en) Anti-OX40L antibodies and methods using same
UA94221C2 (en) Lipocalin protein
WO2008021379A3 (en) Increased activity and efficiency of expansin-like proteins
WO2007039903A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
ZA200704247B (en) Stress tolerant cotton plants
YU9404A (en) Peptide-based multimeric targeted contrast agents
GEP20115356B (en) Metastin derivatives and use thereof
WO2006135793A3 (en) Protein engineering with analogous contact environments
EA200701528A1 (en) NEW NUTRITSEVTIKY COMPOSITIONS
MX2007005202A (en) Modified streptococcal polysaccharides and uses thereof.
WO2005116252A8 (en) Methods for evaluating ribonucleotide sequences
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
HK1154623A1 (en) Isolated luciferases and the use thereof
HK1088016A1 (en) Isolated fluorescent protein from clytia gregaria cgfp and use thereof
EP1987165A4 (en) Genes affecting human memory performance
NZ601647A (en) Variant hhip1 protein and methods and uses thereof
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
TW200640945A (en) Mutants of the fluorescent protein CGFP, and their use
WO2005000870A3 (en) Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof
TW200716177A (en) Isolated photoprotein aqdecay, and its use
TW200617021A (en) Isolated photoprotein aequorin y89f, and its use
TW200716666A (en) Isolated photoprotein gr-bolinopsin, and its use
GB0423126D0 (en) Protein
WO2005057486A3 (en) Protein engineering with analogous contact environments